Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease
Year: 2002
Type: article
Study design: Observational Study
Source: Bone Marrow Transplantation
Authors: S Kumar, RC Wolf, MG Chen, DA Gastineau, MA Gertz, DJ Inwards, MQ Lacy, A Tefferi, MR Litzow
Institution: Mayo Clinic
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2029347729
